5-Year United Kingdom A–BBB Corporate Bond Yield (USD)
Fitted spot yield as of 2026-10-26
https://bondscovery.com/yield-curve/usd-corporate-a-bbb-united-kingdom/5y
5.66%
1 week -7 bp1 month +1 bp6 months +95 bp
The 5-year United Kingdom A–BBB Corporate yield is 5.66% as of 2026-10-26 (1w -7 bp, 1m +1 bp, 6m +95 bp). Fitted from 17 bonds at the 5-year point of the curve, with history, monthly look-back and the bonds priced around it.
5-year yield over time
| 5Y | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| Fitted yield | 5.66% | 5.65% | 5.13% | 5.14% | 4.90% | 4.93% | 4.77% |
| Move to today | — | +1 bp | +53 bp | +53 bp | +76 bp | +74 bp | +89 bp |
Other maturities on this curve
Every maturity on this curve, from the shortest bill to the longest bond, is on the United Kingdom A–BBB Corporate Bond Yields (USD) page.
Bonds around the 5-year mark
30 of the 69 bonds maturing within 20% of 5 years that the 5-year fit is drawn from.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| National Grid | 5.57% | 2030-11-15 | 8.00% | US49337WAC47 |
| BAE Systems | 5.38% | 2031-02-15 | 1.90% | US05523RAF47 |
| BAT | 5.49% | 2031-02-20 | 5.83% | US05526DBY04 |
| Astrazeneca | 5.16% | 2031-02-26 | 4.90% | US04636NAM56 |
| Astrazeneca | 5.25% | 2031-03-02 | 4.00% | US04636NAQ60 |
| CNH | 5.58% | 2031-03-07 | 4.38% | US12592BAW46 |
| Anglo American | 5.61% | 2031-03-17 | 2.88% | USG0446NAV67 |
| Anglo American | 5.64% | 2031-03-19 | 4.62% | USG0446NBB94 |
| Anglo American | 5.66% | 2031-03-17 | 2.88% | US034863BA77 |
| Anglo American | 5.66% | 2031-03-19 | 4.62% | US034863BG48 |
| Lseg | 5.54% | 2031-03-23 | 4.50% | US50222CAE03 |
| BAE Systems | 5.35% | 2031-03-26 | 5.25% | US05523RAK32 |
| BAT | 5.51% | 2031-03-25 | 2.73% | US05526DBS36 |
| Macquarie Airfinance | 6.13% | 2031-03-26 | 6.50% | US55609NAD03 |
| Royalty Pharma | 5.53% | 2031-03-25 | 4.45% | US78081BAT08 |
| Lseg | 5.54% | 2031-04-06 | 2.50% | US50220PAD50 |
| Lseg | 5.47% | 2031-04-06 | 2.50% | USG5690PAD36 |
| Marex Group | 6.44% | 2031-04-21 | 5.68% | US566539AD47 |
| Amcor PLC | 5.55% | 2031-05-25 | 2.69% | US02344AAA60 |
| Astrazeneca | 5.22% | 2031-05-28 | 2.25% | US04636NAB91 |
| Barclays Bank | 5.89% | 2031-06-16 | 5.25% | US06749HGX70 |
| Vodafone | 5.65% | 2031-06-18 | 4.80% | US92857WCC29 |
| CNH | 5.72% | 2031-06-25 | 4.95% | US12592BAX29 |
| Unilever | 5.24% | 2031-08-12 | 1.75% | US904764BQ99 |
| Royalty Pharma | 5.57% | 2031-09-02 | 2.15% | US78081BAN38 |
| GSK Capital INC | 5.32% | 2031-09-15 | 5.00% | US377372AT41 |
| BP PLC | 5.33% | 2032-01-12 | 2.72% | US10373QBT67 |
| Imperial Brands | 5.69% | 2032-02-07 | 4.88% | US45262BAM54 |
| RIO Tinto | 5.40% | 2032-03-14 | 5.00% | US76720AAT34 |
| CSL Finance | 5.55% | 2032-04-27 | 4.25% | USG2584CAC04 |